Mats Wallin, M.D.
Mats Wallin is both an engineer (M.Sc.) and a board certified MD (Anesthesiology and Intensive Care), and holds a PhD in Endocrinology. He is an internationally trusted leading expert in medical devices for anesthesia and intensive care and has recently retired from his position as Medical Director at Maquet Critical Care AB (MCC), one of the world’s largest ICU-ventilator suppliers and a subsidiary to Getinge AB. At MCC he was responsible for medical affairs and pre-clinical and clinical research in anesthesia and advanced monitoring enabling two new class II (Flow-i, EIRUS-monitor), and one class III (EIRUS-CVC), products entering the market. Maquet’s advanced anesthesia machine - Flow-i is the only anesthesia machine with ventilator performance as an ICU-ventilator and has been successfully used in ICUs during the Covid-19 pandemic. The EIRUS- system is a continuous accurate blood-glucose monitoring system for ICU-patients based on a special CVC with a micro-dialysis membrane and two extra ducts used for the blood glucose monitoring function.
Previously he was a senior consultant at the Department of Anesthesiology and Intensive Care at the Karolinska University Hospital. Mats has more than 30 scientific publications and is still an active researcher with ongoing projects in Europe, Australia and Latin-America.
Mats also has an entrepreneurial background as one of the founders of Medair AB, a patient monitoring company producing small class II monitors for ordinary wards and ambulances. Medair was acquired by Nonin 2006. Today he has more than 14 years of board experience in smaller listed public companies (both as a non-executive director as well as being chairman).